Reckitt Benckiser Group PLC (LON:RB) Buy Rating Has Just Been Reiterated by Liberum Capital

July 27, 2018 - By Kristin Houston

Reckitt Benckiser Group plc (LON:RB) Logo

Reckitt Benckiser Group PLC (LON:RB) Rating Reaffirmed

The rating of Reckitt Benckiser Group PLC (LON:RB) shares were kept by stock research analysts at Liberum Capital. This was revealed in an analyst report on Friday, 27 July.

Reckitt Benckiser Group plc (LON:RB) Ratings Coverage

Among 16 analysts covering Reckitt Benckiser Group PLC (LON:RB), 7 have Buy rating, 3 Sell and 6 Hold. Therefore 44% are positive. Reckitt Benckiser Group PLC has GBX 9000 highest and GBX 5000 lowest target. GBX 6546.43’s average target is -2.76% below currents GBX 6732 stock price. Reckitt Benckiser Group PLC had 45 analyst reports since January 29, 2018 according to SRatingsIntel. The rating was maintained by Deutsche Bank on Friday, March 23 with “Buy”. The company was maintained on Tuesday, May 8 by BNP Paribas. The rating was maintained by Kepler Cheuvreux on Thursday, February 22 with “Hold”. Berenberg maintained the stock with “Buy” rating in Tuesday, April 24 report. Morgan Stanley maintained it with “Overweight” rating and GBX 8500 target in Thursday, March 22 report. On Monday, March 12 the stock rating was maintained by JP Morgan with “Overweight”. BNP Paribas maintained Reckitt Benckiser Group plc (LON:RB) on Wednesday, January 31 with “Neutral” rating. Liberum Capital maintained Reckitt Benckiser Group plc (LON:RB) rating on Wednesday, March 7. Liberum Capital has “Buy” rating and GBX 8000 target. On Monday, January 29 the stock rating was maintained by Investec with “Sell”. The stock of Reckitt Benckiser Group plc (LON:RB) has “Underperform” rating given on Friday, May 4 by Credit Suisse.

The stock increased 6.67% or GBX 421 during the last trading session, reaching GBX 6732. About 1.23 million shares traded. Reckitt Benckiser Group plc (LON:RB) has 0.00% since July 27, 2017 and is . It has underperformed by 12.57% the S&P500.

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company has market cap of 47.56 billion GBP. The firm offers treatment products for analgesic and gastro-intestinal problems, sore throat, cough, pain, and flu, as well as wellness products in sexual wellbeing, footcare, vitamins, and supplements under the Durex, Gaviscon, Nurofen, Mucinex, Scholl, and Strepsils brand names. It has a 7.76 P/E ratio. It also offers hygienic products, including surface care and lavatory care products, antiseptic liquids, pest control products, automatic dishwashing products, automatic dishwashing products, and depilatory products under the Cillit Bang, Clearasil, Dettol, Finish, Harpic, Lysol, Mortein, and Veet brand names.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.